EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity

Weidong Ye, Junyuan Xiao, Jiaxin Li, Cheng Yang, Chunlai Li, Zhifeng Xi, Zhuoan Cheng

Cellular Oncology · 13.05.2026 · 49 (4)

DOI: 10.1007/s13402-026-01200-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 13.05.2026. Verfasst von Weidong Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Medical College, Fudan University Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, Super Enhancers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingSuper EnhancersHistone DeacetylasesGene Expression Regulation, NeoplasticDisease ProgressionNuclear Pore Complex ProteinsHumansAnimalsCell Line, TumorCell ProliferationMaleCell MovementMice, NudeFemale

Stichwörter der Autor:innen

HCCHDAC11HDAC11-AS1NUP210SE-lncRNAs

Substanzen

RNA, Long NoncodingHistone DeacetylasesHDAC11 protein, humanNuclear Pore Complex Proteins

Autor:innen und Institutionen

  • Department of Oncology, Shanghai Medical College, Fudan University Fudan University Shanghai Cancer Center, Shanghai, China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. czan0907@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ye, W., Xiao, J., Li, J., Yang, C., Li, C., Xi, Z., & Cheng, Z. (2026). Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity. Cellular Oncology, 49(4). https://doi.org/10.1007/s13402-026-01200-x

Vancouver

Ye W, Xiao J, Li J, Yang C, Li C, Xi Z, et al. Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity. Cellular Oncology. 2026;49(4). doi:10.1007/s13402-026-01200-x

BibTeX
@article{Ye2026,
  author = {Ye, Weidong and Xiao, Junyuan and Li, Jiaxin and Yang, Cheng and Li, Chunlai and Xi, Zhifeng and Cheng, Zhuoan},
  title = {Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity},
  journal = {Cellular Oncology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1007/s13402-026-01200-x}
}
Kostenlos starten →